Literature DB >> 2973530

Re: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762.

H J deVoogt, M Pavone-Macaluso, R Sylvester, F H Schröder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973530     DOI: 10.1016/s0022-5347(17)42118-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  2 in total

1.  The evolution of hormonal therapy for prostatic carcinoma.

Authors:  M K Brawer
Journal:  Rev Urol       Date:  2001

Review 2.  Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.

Authors:  C M Perry; D McTavish
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.